Navigation Links
North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
Date:5/28/2013

Manhasset, NY (PRWEB) May 28, 2013

The 2013 Commencement Exercises for the Elmezzi Graduate School of Molecular Medicine and the Academic Convocation for the Hofstra North Shore-LIJ School of Medicine were held May 23 at The Feinstein Institute for Medical Research. Each year during this event, the Elmezzi Graduate School awards an honorary degree to an outstanding physician who has advanced biomedical research and improved medical treatment for patients. This year, Frederick W. Alt, PhD, from Harvard Medical School and Boston Children's Hospital, was recognized for his work in cancer and immunology.

During the commencement exercises for the Elmezzi Graduate School, students who have completed their dissertation studies are granted the degree of Doctor of Philosophy, Molecular Medicine. The Elmezzi Graduate School of Molecular Medicine is a PhD program for physicians who wish to pursue careers in biomedical education. During their training, Elmezzi students conduct research in Feinstein Institute laboratories to advance biomedical knowledge and to pursue new therapeutic approaches and diagnostic tools. This year, three graduate students received their degrees:

  •     Eitan Giat, MD, for his work in lupus. His thesis is entitled “The Inhibition of the Interferon Signature by the Dweus Peptide through Inactivation of HMGB1.”
  •     Ben Lu, MD, for his work in inflammation. His thesis is entitled “The Regulation of HMGB1 Release.”
  •     Sergio I. Valdes-Ferrer, MD, for his work in sepsis. His thesis is entitled “HMGB1 is a Key Mediator of Sustained Inflammation in Sepsis Survivors.”

The academic convocation for the Hofstra North Shore-LIJ School of Medicine acknowledged all current professorships and presented the new School of Medicine professors. Those who received honorary professorships include:

  •     Veronica M. Catanese, MD, MBA, vice dean/dean for Academic Affairs of Hofstra North Shore-LIJ School of Medicine, received the Dr. Leo A. Guthart Endowed Chair.
  •     Betty Diamond, MD, head of the Center for Autoimmune and Musculoskeletal Diseases at the Feinstein Institute, received the Maureen and Ralph Nappi Professor of Autoimmune Diseases at The Feinstein Institute for Medical Research.
  •     Samuel Packer, MD, professor of Ophthalmology at the Hofstra North Shore-LIJ School of Medicine, received the Florence and Robert Kaufman Professor of Medical Ethics.
  •     Charles Schleien, MD, professor of Pediatrics at the Hofstra North Shore-LIJ School of Medicine, received the Philip Lanzkowsky, MD Professor of Pediatrics.

In addition, Frederick W. Alt, PhD, was presented with an honorary degree: Candidate for Degree of Doctor of Science honoris causa. Dr. Alt is the Charles A. Janeway Professor of Pediatrics in the Department of Pediatrics at Harvard Medical School, a professor in the Department of Genetics at Harvard Medical School, and an investigator in the Howard Hughes Medical Institute at Boston Children's Hospital. Throughout his career, Dr. Alt has studied cellular mechanisms that generate and suppress genome instability associated with cancer and the mechanisms employed by the immune system to generate diverse antibody repertoires. His current work continues to focus on areas where the fields of cancer biology and immunology intersect.

About The Elmezzi Graduate School of Molecular Medicine

Located in Manhasset, NY, The Elmezzi Graduate School of Molecular Medicine is part of the North Shore-LIJ Health System and in partnership with The Feinstein Institute for Medical Research. The Elmezzi Graduate School of Molecular Medicine was established in 1994 and is a PhD program for physicians who wish to pursue careers in biomedical research. The program is an individually tailored program with a strong emphasis on translational research. For more information, visit http://www.ElmezziGraduateSchool.org.

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10775139.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New online portal, app provide information on tsunami zones in the Northwest
2. A North American first at the Montreal Heart Institute
3. Symtrex Inc. Signs Up with ImmuneSecurity to Launch LogInspect to the North American Market
4. Northwestern launches comprehensive program for patients with bicuspid aortic valve disease
5. Northwestern Medicine hosts the National Marfan Foundations Annual Conference
6. Northwestern researchers investigate treatment for tumor cells in spinal fluid
7. North Texas Cities to Start West Nile Spraying Thursday
8. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
9. Power Slowly Returns to Much of Northeast After Sandy
10. Kessler awarded $2 million federal grant for Northern NJ Traumatic Brain Injury System
11. Heart Health Worst in the South, Best in Northeast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
(Date:10/12/2017)... ... 12, 2017 , ... Farm Forward joins Bon ... leading institutions in announcing the launch of the Leadership Circle , a ... are raised for food. , Founding members of the Leadership Circle also include ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
(Date:10/7/2017)... Oct. 6, 2017   Provista, a proven ... $100 billion in purchasing power, today announced a new ... The Newsroom is the online home for ... infographics, expert bios, news releases, slideshows and events. ... a wealth of resources at their fingertips, viewers can ...
Breaking Medicine Technology: